Science Explorer Back to mapMap
Discussion
Company · Bozeman · United States

SiteOne Therapeutics (United States)

Research works
12
▼ 65% vs 2018-21
Citations
227
18.8 per fractional work
Top-10% rate
30.0%
all institutions 10.0%
Open access
59%
world 40%
International
13%
world 18%

Not ranked overall: SiteOne Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does SiteOne Therapeutics (United States) work in?

In all years, 38% of research at SiteOne Therapeutics (United States) is in Health Sciences, 36% in Life Sciences. Its largest fields are Medicine (34%), Biochemistry, Genetics and Molecular Biology (22%), Environmental Science (10%). It does 1.5× the world's share of Life Sciences.

Health Sciences: 5 fractional works · 38.1% of its workMedicine: 4 fractional works · 34.4% of its workPhysiology: 1 fractional works · 5.1% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 4.1% of its workEpidemiology: 0 fractional works · 3.9% of its workSurgery: 0 fractional works · 3.3% of its workPulmonary and Respiratory Medicine: 0 fractional works · 3.2% of its workOphthalmology: 0 fractional works · 3.0% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 3.0% of its workDermatology: 0 fractional works · 2.7% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 2.3% of its workPathology and Forensic Medicine: 0 fractional works · 1.8% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.4% of its workNeurology: 0 fractional works · 0.2% of its workOncology: 0 fractional works · 0.2% of its workVeterinary: 0 fractional works · 2.7% of its workSmall Animals: 0 fractional works · 2.7% of its workHealth Professions: 0 fractional works · 0.9% of its workPhysical Therapy, Sports Therapy and Rehabilitation: 0 fractional works · 0.9% of its workLife Sciences: 4 fractional works · 35.7% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 21.9% of its workMolecular Biology: 2 fractional works · 16.7% of its workBiochemistry: 0 fractional works · 2.3% of its workClinical Biochemistry: 0 fractional works · 2.1% of its workGenetics: 0 fractional works · 0.6% of its workCell Biology: 0 fractional works · 0.2% of its workNeuroscience: 1 fractional works · 7.0% of its workCellular and Molecular Neuroscience: 0 fractional works · 3.2% of its workNeurology: 0 fractional works · 2.7% of its workSensory Systems: 0 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 1 fractional works · 5.4% of its workInsect Science: 0 fractional works · 2.7% of its workAnimal Science and Zoology: 0 fractional works · 2.1% of its workAquatic Science: 0 fractional works · 0.6% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.4% of its workPharmacology: 0 fractional works · 1.4% of its workPhysical Sciences: 2 fractional works · 17.8% of its workEnvironmental Science: 1 fractional works · 10.3% of its workManagement, Monitoring, Policy and Law: 0 fractional works · 4.1% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 2.7% of its workGlobal and Planetary Change: 0 fractional works · 1.3% of its workEnvironmental Chemistry: 0 fractional works · 0.9% of its workEcology: 0 fractional works · 0.6% of its workNature and Landscape Conservation: 0 fractional works · 0.6% of its workEarth and Planetary Sciences: 0 fractional works · 4.1% of its workGeophysics: 0 fractional works · 2.1% of its workAtmospheric Science: 0 fractional works · 2.0% of its workChemistry: 0 fractional works · 2.1% of its workAnalytical Chemistry: 0 fractional works · 2.1% of its workMaterials Science: 0 fractional works · 1.4% of its workMaterials Chemistry: 0 fractional works · 1.4% of its workSocial Sciences: 1 fractional works · 8.4% of its workSocial Sciences: 1 fractional works · 8.4% of its workPolitical Science and International Relations: 1 fractional works · 4.7% of its workSociology and Political Science: 0 fractional works · 1.5% of its workLife-span and Life-course Studies: 0 fractional works · 0.9% of its workLaw: 0 fractional works · 0.6% of its workGeography, Planning and Development: 0 fractional works · 0.3% of its workTransportation: 0 fractional works · 0.3% of its workALL ITS WORKSiteOneTherapeutics…12fractional works, all years
Life Sciences36%Physical Sciences18%Health Sciences38%Social Sciences8%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Medicine434.4%
    2. Veterinary02.7%
    3. Health Professions00.9%
    1. Biochemistry, Genetics and Molecular Biology321.9%
    2. Neuroscience17.0%
    3. Agricultural and Biological Sciences15.4%
    4. Pharmacology, Toxicology and Pharmaceutics01.4%
    1. Environmental Science110.3%
    2. Earth and Planetary Sciences04.1%
    3. Chemistry02.1%
    4. Materials Science01.4%
    1. Social Sciences18.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at SiteOne Therapeutics (United States)?

Ranked on the quality score, Henry L. White and Anton Delwig lead among researchers whose main affiliation is SiteOne Therapeutics (United States).

  1. 1 Henry L. White United States · #2,023,474 worldwide 118 citations · 81 works
  2. 2 Anton Delwig United States · #2,237,102 worldwide 517 citations · 28 works
All ranked researchers at SiteOne Therapeutics (United States)

What are the most cited papers from SiteOne Therapeutics (United States)?

The most cited paper from SiteOne Therapeutics (United States) is "Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na V 1.7" (John V. Mulcahy, Hassan Pajouhesh, Jacob T. Beckley et al., 2019), with 101 citations. Next come "1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia" (72) and "Discovery of a selective, state-independent inhibitor of NaV1.7 by modification of guanidinium toxins" (44).

Most cited papers
#PaperReleasedCitations
1 Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na V 1.7 John V. Mulcahy, Hassan Pajouhesh, Jacob T. Beckley et al. · Journal of Medicinal Chemistry Open access 23 Apr 2019 101
2 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia Sampath‐Kumar Anandan et al. · Bioorganic & Medicinal Chemistry Letters Open access 14 Dec 2010 72
3 Discovery of a selective, state-independent inhibitor of NaV1.7 by modification of guanidinium toxins Hassan Pajouhesh, Jacob T. Beckley, Anton Delwig et al. · Scientific Reports Open access 9 Sep 2020 44
4 Antinociceptive properties of an isoform-selective inhibitor of Nav1.7 derived from saxitoxin in mouse models of pain Jacob T. Beckley, Hassan Pajouhesh, George Luu et al. · Pain Open access 15 Oct 2020 36
5 Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N′-diaryl urea inhibitors of soluble epoxide hydrolase Sampath‐Kumar Anandan, Richard D. Gless · Bioorganic & Medicinal Chemistry Letters Open access 23 Mar 2010 23
All 23 most cited papers, with filters and sorting

Which research topics does SiteOne Therapeutics (United States) publish most on?

By volume in 2022-now: Neuroscience and Neuropharmacology Research, Ion channel regulation and function, Nicotinic Acetylcholine Receptors Study and Plant Water Relations and Carbon Dynamics.

  1. 1 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 0 works
  2. 2 Ion channel regulation and function Molecular Biology 0 works
  3. 3 Nicotinic Acetylcholine Receptors Study Molecular Biology 0 works
  4. 4 Plant Water Relations and Carbon Dynamics Global and Planetary Change 0 works
  5. 5 Biochemical effects in animals Physiology 0 works
  6. 6 Geology and Paleoclimatology Research Atmospheric Science 0 works
  7. 7 Tree-ring climate responses Atmospheric Science 0 works
  8. 8 Neuroblastoma Research and Treatments Neurology 0 works
  9. 9 Cancer Treatment and Pharmacology Oncology 0 works
  10. 10 Microtubule and mitosis dynamics Cell Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available58.8%not open41.2%

World: 40% of research is openly available.

with international co-authors12.7%domestic only87.3%

World: 18% is written across borders.

How has SiteOne Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 65% lower than in 2018-2021.

1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is SiteOne Therapeutics (United States) as a percentage of every work published that year, 0.0000031% in 2023.

0.00010%0.00020%0.00030%SiteOne Therapeutics (United States)0.0000060% in 202419801990200020102020

Fractional works of SiteOne Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Bozeman

All research institutions in Bozeman

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about SiteOne Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.